MedicinefromPsychology Today2 weeks agoKetamine Holds Promise for Cognitive Benefits, Study ShowsLow-dose ketamine induces neuroplasticity, treats refractory depression rapidly, and shows potential to improve cognitive deficits in neurological and psychiatric disorders.
Mental healthfromHarvard Gazette1 month agoFirst study to compare ketamine therapies for patients with severe depression - Harvard GazetteIV ketamine produces faster and greater reductions in depression severity than intranasal esketamine for treatment-resistant depression.
Mental healthfromPsychology Today3 months agoThe Scopolamine BreakthroughScopolamine produces rapid antidepressant effects and targets muscarinic receptors, offering hope for treatment-resistant depression.